Inventor
KLAUS KOPKA
Inventor
DE
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes23%
C07DHeterocyclic compounds23%
G01NInvestigating or analysing materials by determining their chemical or physical properties23%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations12%
C07BGeneral methods of organic chemistry12%
C07KPeptides4%
C09BOrganic dyes or closely-related compounds for producing dyes, e.g. pigments4%
PatentTitleYear
12,156,920Double-labeled probe for molecular imaging and use thereof202412,054,458None202411,951,190Use of labeled inhibitors of prostate specific membrane antigen (PSMA), as agents for the treatment of prostate cancer202411,931,430Labeled inhibitors of prostate specific membrane antigen (PSMA) as agents for the treatment of prostate cancer202411,638,765Double-labeled probe for molecular imaging and use thereof202311,452,786Double-labeled probe for molecular imaging and use thereof2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2024Patents assigned to DEUTSCHES KREBSFORSCH (6)· patent assignee history
2022–2024Patents assigned to UNIV HEIDELBERG RUPRECHT KARLS (5)· patent assignee history
2022–2024Based in DE· patent location history
2023Patents assigned to RUPRECHT KARLS UNI VERSITAET HEIDELBERG (1)· patent assignee history
2024Patents assigned to NOVARTIS AG (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| DEUTSCHES KREBSFORSCH | 6 | 2022–2024 |
| UNIV HEIDELBERG RUPRECHT KARLS | 5 | 2022–2024 |
| NOVARTIS AG | 2 | 2024 |
| RUPRECHT KARLS UNI VERSITAET HEIDELBERG | 1 | 2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| DE | 6 | 2022–2024 |